EGFR and breast carcinoma: Uhlmann et al. demonstrated that three miRNAs, miR-124, miR-147, and miR-193a-3p, co-target EGFR-related pathway proteins, leading to an inhibition of cell-cycle progression and cell proliferation in breast cancer cell models through global miRNA screening using a high-throughput proteomic analysis [36].